Study assessing efficacy of BNT162b2 mRNA COVID-19 vaccine in patients with B-cell malignancies treated with anti-CD20 antibody
Latest Information Update: 28 Jan 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 28 Jan 2022 New trial record
- 01 Jan 2022 Results published in the International Journal of Hematology
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition